Main Content
Innovations for COPD Medicine - New Paradigms for Prevention and Treatment
Scientific Organizing Committee: B. Schmeck, C. Vogelmeier, G. Rohde, M. Lehmann
Thursday, July 2nd, 2026
Session 1: Chronic Airway Diseases - the Big Picture
Chair: Bernd Schmeck
| 12:30 | Welcome Address by Bernd Schmeck |
| 12:40 |
Ian Adcock (Imperial College London) KEYNOTE: Molecular Phenotypes of Severe Asthma |
| 13:15 |
Stefan Karrasch (Ludwig Maximilians-University München) Lung Function Parameters as Biomarkers |
| 13:50 |
Katherina Sewald (Fraunhofer ITEM, Hannover) Advanced in vitro/ex vivo Models for the Development of Biologics |
| 14:25 |
Gernot Rohde (Philipps-University Marburg) Respiratory Virus-driven Inflammation as a Trigger of COPD Exacerbations |
| 15:00 |
Roman Martin (Westfälische Wilhelms-Universität Münster) Biomarker Discovery Through the COSYCONET Cohort |
| 15:35 |
Coffee and Tea Break |
Session 2: Chronic Airway Diseases - Understanding and Treating
Chair: Claus Vogelmeier
| 16:10 |
Pontus Mertsch (Ludwig Maximilians-University München) Between Infection and Inflammation: Neutrophilic Inflammation in Bronchiectasis and its Implications for Treatment Approaches |
| 16:45 |
Tobias Niedermaier (Ludwig Maximilians-University München) Costs in COPD Patients over Time – Use of Longitudinal Data from COSYCONET |
| 17:20 |
Mareike Lehmann (Philipps-University Marburg) Regeneration of the Aging Lung |
| 17:55 |
Martin Witzenrath (Charité Universitätsmedizin Berlin) KEYNOTE: Respiratory Medicine in the Twenty-thirties |
| 18:30 |
Enjoy the food and disussions! |
Friday, July 3rd, 2026
Session 3: COPD - Lessons for Personalized Treatment
Chair: Gernot Rohde
| 9:00 |
Welcome Address |
| 9:05 |
Rosa Faner (Clínic Barcelona) KEYNOTE: Phenotypes, Endotypes, GETomics, the Trajectome, Syndemics, and Treatable Traits |
| 9:40 |
Claus Vogelmeier (Philipps-University Marburg) Drug Therapy for COPD - New Developments |
| 10:15 |
Rembert Koczulla (Schön Klinik Berchtesgadener Land) COPD - Individualized Diagnostics and Therapy - What Can We Learn from the PACE Study? |
| 10:50 |
Viktoria Palm (University Clinic Heidelberg) AI-based CT Analysis Identifies IMAT as an Independent Predictor of Vascular Calcification and Modulator of the Bone-Vascular Axis in COPD Patients |
| 11:25 |
Coffee and Tea Break |
Session 4: COPD - To Boldly Go where No-one Has Gone Before
Chair: Peter Alter
| 12:00 |
Tim Greulich (University Clinic Marburg) Patient -Stratification – Can It Be Implemented in a High-throughput Outpatient Care System? |
| 12:35 |
Bernd Schmeck (Philipps-University Marburg) Treating the Untreatable – an AI-based Platform for New Interventional Studies for Chronic Lung Diseases |
| 13:10 |
Frits Franssen (University of Maastricht) KEYNOTE: Predicting Exacerbations in COPD: the Holy Grail |
| 13:45 |
Bernd Schmeck Conclusions, Prospects, and Farewell |
